DENVER, March 14 /PRNewswire-FirstCall/ -- Cochlear Americas announced
today that it recently received approval from the U.S. Food and Drug
Administration (FDA) to market the Nucleus(R) Freedom(TM) cochlear implant
system. The Nucleus Freedom, which features both an internal component and an
external speech processor, will begin shipping to clinics on April 3, 2005.
The Nucleus Freedom is designed to mimic functions of the human ear and fit
seamlessly into a user's lifestyle.
(Photo: http://www.newscom.com/cgi-bin/prnh/20050314/NYM180-a )
"The Nucleus Freedom offers a variety of innovative features designed to
provide users with an experience more similar to natural hearing, allowing
them the freedom to interact more fully with the world around them," said
Chris Smith, President, Cochlear Americas. "For instance, the Nucleus Freedom
is the first device to offer SmartSound(TM), a combination of three unique
sound technologies designed to enable better hearing in everyday listening
situations. It is also the only cochlear implant system with a water resistant
speech processor, allowing users to participate in activities around water
while wearing the speech processor."
The Nucleus Freedom implant features the Contour Advance(TM) electrode, a
self-curling electrode array that allows the electrodes to be placed close to
the hearing nerve for targeted stimulation and increased power efficiency,
while applying minimal pressure on the cochlear structures. The Contour
Advance is the only electrode array designed to protect cochlear structures
during surgery, which leading medical professionals say is essential in
preserving residual hearing.
Additional Features of the Nucleus Freedom
The Nucleus Freedom also offers the following features:
* SmartSound(TM) Beam(TM), the first and only two-microphone system
designed to soften distracting background sounds allowing for focused
listening in crowds.
* SmartSound(TM) ADRO(TM), which automatically adjusts sound levels to
deliver a balance of clarity and comfort. Ideal for listening to music
and in dynamic environments.
* SmartSound(TM) Whisper(TM), which enhances softer sounds allowing
recipients to understand them more clearly.
* Up to five days of battery life. Unlike other systems that rely on
brand-specific rechargeable batteries that last only a few hours, the
Nucleus Freedom can operate on one set of commercially available
batteries for up to five days, depending on the user's coding strategy
About Cochlear Implants
Cochlear implants are a proven medical option for adults and children with
severe to profound hearing loss. They are electronic devices, which bypass
damaged hair cells in the inner ear, or cochlea, and stimulate the hearing
nerve directly. Cochlear implants provide useful hearing and improved
communication abilities to those who receive little or no benefit from hearing
aids. They are the only medical device designed to restore one of the five
About Cochlear(TM) Americas
Since launching the world's first cochlear implant system more than
20 years ago, Cochlear Limited and its US headquarters, Cochlear Americas,
have brought the miracle of sound to more than 60,000 hearing-impaired
individuals across the globe. Cochlear's state-of-the-art technologies, based
on extensive research and development at preeminent academic institutions,
restore the ability to hear sound and understand speech-enhancing both
learning capabilities and quality of life for those with severe to profound
hearing loss. Cochlear has remained the market leader in its field thanks to
an unwavering commitment to innovation, reliability and customer support.
Numerous awards, as well as published scientific data, attest to Cochlear's
outstanding product line and unsurpassed performance. Cochlear's promise "Hear
Now. And Always." reflects its dedication to durability and service. For more
information about Cochlear's products, call the Cochlear Nucleus(R) Hotline at
800/458-4999 (Voice) or 800/483-3123 (TTY) or visit the Web site at
SOURCE Cochlear Americas